Charmacy Pharmaceutical Bilan de santé
Santé financière contrôle des critères 2/6
Charmacy Pharmaceutical has a total shareholder equity of CN¥592.2M and total debt of CN¥948.8M, which brings its debt-to-equity ratio to 160.2%. Its total assets and total liabilities are CN¥3.3B and CN¥2.7B respectively. Charmacy Pharmaceutical's EBIT is CN¥129.4M making its interest coverage ratio 2.5. It has cash and short-term investments of CN¥417.4M.
Informations clés
160.2%
Ratio d'endettement
CN¥948.84m
Dette
| Ratio de couverture des intérêts | 2.5x |
| Argent liquide | CN¥417.41m |
| Fonds propres | CN¥592.15m |
| Total du passif | CN¥2.68b |
| Total des actifs | CN¥3.27b |
Mises à jour récentes de la santé financière
These 4 Measures Indicate That Charmacy Pharmaceutical (HKG:2289) Is Using Debt Reasonably Well
Oct 25
Is Charmacy Pharmaceutical (HKG:2289) A Risky Investment?
May 02Recent updates
There Could Be A Chance Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) CEO Will Have Their Compensation Increased
May 13There's Reason For Concern Over Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) Massive 40% Price Jump
Apr 24Charmacy Pharmaceutical Co., Ltd. (HKG:2289) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jan 19These 4 Measures Indicate That Charmacy Pharmaceutical (HKG:2289) Is Using Debt Reasonably Well
Oct 25If EPS Growth Is Important To You, Charmacy Pharmaceutical (HKG:2289) Presents An Opportunity
Sep 17Is Charmacy Pharmaceutical (HKG:2289) A Risky Investment?
May 02What Type Of Returns Would Charmacy Pharmaceutical's(HKG:2289) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Mar 15Are Dividend Investors Making A Mistake With Charmacy Pharmaceutical Co., Ltd. (HKG:2289)?
Feb 17We Wouldn't Rely On Charmacy Pharmaceutical's (HKG:2289) Statutory Earnings As A Guide
Jan 27Returns On Capital At Charmacy Pharmaceutical (HKG:2289) Paint An Interesting Picture
Jan 09What Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) ROE Can Tell Us
Dec 22
Reflecting on Charmacy Pharmaceutical's (HKG:2289) Share Price Returns Over The Last Three Years
Nov 29Analyse de la situation financière
Passif à court terme: 2289's short term assets (CN¥2.8B) exceed its short term liabilities (CN¥2.6B).
Passif à long terme: 2289's short term assets (CN¥2.8B) exceed its long term liabilities (CN¥40.5M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 2289's net debt to equity ratio (89.7%) is considered high.
Réduire la dette: 2289's debt to equity ratio has increased from 108.8% to 160.2% over the past 5 years.
Couverture de la dette: 2289's operating cash flow is negative, therefore debt is not well covered.
Couverture des intérêts: 2289's interest payments on its debt are not well covered by EBIT (2.5x coverage).